Join us for a talk with Medical Oncologist and Senior Lecturer in Experimental Cancer Medicine Stefan Symeonides. Follow the link to our Facebook event for the latest updates.

About the Speaker

Stefan Symeonides is a Medical Oncologist and Senior Lecturer in Experimental Cancer Medicine at the Edinburgh Cancer Research Centre and at the linked Edinburgh Cancer Centre (NHS Lothian). After clinical training in the UK (Cambridge & Edinburgh), Australia (Melbourne) & New Zealand (Christchurch), and research in academia (Cambridge & Edinburgh), clinic (Edinburgh) and industry (AstraZeneca, various UK Biotechs), he is currently in a CSO Clinician Scientist Fellowship and leads bridging the space between pre-clinical and clinical cancer drug development in Edinburgh, linking laboratory and clinical research.

​

In the clinic, he leads the Phase I Trials Unit and also has a specialty focus on renal cancers within the Uro-oncology team.  He leads a growing portfolio of early phase trials and also continues in drug development, working with CRUK’s Centre for Drug Development and in an advisory role for a number of UK Biotechs.

​

His research focus is on novel therapeutic discovery and development.  His main focus is immunotherapies and he is the clinical lead for the Edinburgh Cancer Immunology Research Network.  He is particularly interested in combining cancer immunotherapies to improve their activity.  His current FAK-PD1 trial (NCT02758587) of combination PD-1 (pembrolizumab) and FAK (defactinib) inhibition is an example of how scientific discoveries at the Edinburgh Cancer Research Centre are being translated into the clinic.